The active enantiomer nutlin-3a is known to stabilize p53 and activate its target genes, exerting a vast array of biological effects in preclinical models of p53wt cancer cells of different origins, thereby restoring its biological activity (Romani et al., 2022; Wang and Yan, 2011; Psatha et al., 2023). Here, TP53 is linked to cancer.